Etranacogene Dezaparvovec Gene Therapy for Haemophilia B (HOPE-B): 24-month Post-hoc Efficacy and Safety Data from a Single-arm, Multicentre, Phase 3 TrialCoppens, Michiel & 74 more2024PDF4.6 MBEN
